
A novel scoring system for adjuvant irradiation in stage I/II oral squamous cell carcinoma (OSCC) was developed and validated. Patients were categorized into low and high-risk groups based on factors like tumor size, invasion depth, and histological features. High-risk patients received adjuvant irradiation, reducing its use by 38% without compromising disease-free survival (DFS). This study highlights a personalized approach to treatment decision-making in early-stage OSCC.
Like
Save
Share